Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2800 participants.

Also called NCT05476991

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 2,800 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05476991
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05476991. Randomized; no masking; primary purpose treatment. Start 2023-05-17 (actual); primary completion 2027-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
Acronym
RIISC-THETIS
Condition
Stroke
Condition
Stroke, Ischemic
Condition
Atherosclerosis
Condition
Coronary Syndrome
Condition
Cardiac Disease
Condition
Cerebral Infarction
Intervention (Drug)
Colchicine 0.5 MG
Intervention (Drug)
Ticagrelor 90mg
Intervention (Drug)
Aspirin 75-300mg
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)

Record details

Record id
cardio:ct-nct05476991
Content hash
9877b2a6ed2209e20dfc3a3c9721f1e09ffab035562d441bbb5d243d634ab5c0